Cito Capital Group LLC decreased its stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 22.5% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 17,200 shares of the pharmacy operator’s stock after selling 5,000 shares during the period. Cito Capital Group LLC’s holdings in Walgreens Boots Alliance were worth $809,000 as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds also recently modified their holdings of the company. Strategic Blueprint LLC acquired a new stake in Walgreens Boots Alliance during the second quarter worth approximately $38,000. Newbridge Financial Services Group Inc. bought a new position in shares of Walgreens Boots Alliance in the second quarter valued at approximately $40,000. Centerpoint Advisors LLC lifted its holdings in shares of Walgreens Boots Alliance by 38.7% in the third quarter. Centerpoint Advisors LLC now owns 986 shares of the pharmacy operator’s stock valued at $46,000 after purchasing an additional 275 shares in the last quarter. SouthState Corp bought a new position in shares of Walgreens Boots Alliance in the third quarter valued at approximately $56,000. Finally, Strategic Asset Management LLC bought a new position in shares of Walgreens Boots Alliance in the third quarter valued at approximately $66,000. 55.33% of the stock is owned by institutional investors.
In other Walgreens Boots Alliance news, Director Nancy M. Schlichting sold 2,725 shares of the company’s stock in a transaction dated Friday, November 19th. The shares were sold at an average price of $47.16, for a total value of $128,511.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 17.40% of the company’s stock.
Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings data on Thursday, January 6th. The pharmacy operator reported $1.68 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.35 by $0.33. Walgreens Boots Alliance had a net margin of 4.76% and a return on equity of 20.28%. The business had revenue of $33.90 billion during the quarter, compared to the consensus estimate of $32.87 billion. During the same period in the previous year, the firm posted $1.22 earnings per share. The business’s revenue for the quarter was down 6.6% compared to the same quarter last year. As a group, sell-side analysts anticipate that Walgreens Boots Alliance, Inc. will post 5.05 EPS for the current year.
The company also recently disclosed a quarterly dividend, which was paid on Friday, December 10th. Shareholders of record on Monday, November 15th were given a $0.477 dividend. The ex-dividend date was Friday, November 12th. This represents a $1.91 dividend on an annualized basis and a dividend yield of 3.56%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is currently 25.74%.
A number of research analysts have recently weighed in on WBA shares. Morgan Stanley lowered Walgreens Boots Alliance from an “equal weight” rating to an “underweight” rating and dropped their target price for the company from $56.00 to $49.00 in a report on Thursday, December 16th. Zacks Investment Research raised Walgreens Boots Alliance from a “sell” rating to a “hold” rating and set a $56.00 target price for the company in a research report on Tuesday, January 4th. TheStreet raised Walgreens Boots Alliance from a “c+” rating to a “b-” rating in a research report on Monday, January 3rd. Truist Securities lifted their price target on Walgreens Boots Alliance from $52.00 to $56.00 and gave the company a “hold” rating in a research report on Friday, October 15th. Finally, Mizuho lifted their price target on Walgreens Boots Alliance from $51.00 to $56.00 in a research report on Monday. One analyst has rated the stock with a sell rating, eleven have issued a hold rating and one has given a buy rating to the company. Based on data from MarketBeat, Walgreens Boots Alliance has an average rating of “Hold” and a consensus target price of $54.53.
Walgreens Boots Alliance Profile
Walgreens Boots Alliance, Inc engages in the provision of drug store services. It operates through the following segments: Retail Pharmacy USA and Retail Pharmacy International. The Retail Pharmacy USA segment consists of the Walgreens business, which includes the operation of retail drugstores, health and wellness services, and mail and central specialty pharmacy services.
Featured Story: Institutional Investors
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBA).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.